Stock DNA
Pharmaceuticals & Biotechnology
INR 108 Cr (Micro Cap)
NA (Loss Making)
40
0.00%
0.61
-37.46%
5.25
Total Returns (Price + Dividend) 
Cian Healthcare for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News
Announcements 
Board Meeting Outcome for Board Meeting Held On November 13 2026
13-Nov-2026 | Source : BSEAs per the Attachment.
Un-Audited Financial Results (Standalone And Consolidated) For The Half Year Ended September 30 2026
13-Nov-2026 | Source : BSEAs per the Attachment.
Board Meeting Intimation for The Meeting (CIAN/BM/2026-27/03) Of The Board Of Directors Scheduled To Be Held On Friday November 13 2026.
08-Nov-2026 | Source : BSECian Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 inter alia to consider and approve The (Both Standalone and Consolidated) Financial Results for the half-year ended September 30 2026.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Ananta Medicare Limited (55.0%)
None
4.34%
Half Yearly Results Snapshot (Standalone) - Mar'25
Growth in half year ended Mar 2025 is -33.48% vs -34.08% in Sep 2024
Growth in half year ended Mar 2025 is 73.32% vs -1,185.31% in Sep 2024
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is -47.44% vs -13.04% in Mar 2024
YoY Growth in year ended Mar 2025 is -5,141.03% vs -64.55% in Mar 2024